These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 10812246)

  • 21. Quantitative expression of toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides.
    Hornung V; Rothenfusser S; Britsch S; Krug A; Jahrsdörfer B; Giese T; Endres S; Hartmann G
    J Immunol; 2002 May; 168(9):4531-7. PubMed ID: 11970999
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oligonucleotide IMT504 induces an immunogenic phenotype and apoptosis in chronic lymphocytic leukemia cells.
    Rodriguez JM; Elias F; Montaner A; Flo J; Lopez RA; Zorzopulos J; Franco RJ; Lenial SP; Lopez Salón M; Pirpignani ML; Solimano J; Garay G; Riveros D; Fernandez J; Cacchione R; Dupont J
    Medicina (B Aires); 2006; 66(1):9-16. PubMed ID: 16555722
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of IL-2R beta-binding cytokines on costimulatory properties of chronic lymphocytic leukaemia cells: implications for immunotherapy.
    Spaner DE; Hammond C; Mena J; Shi Y
    Br J Haematol; 2004 Dec; 127(5):531-42. PubMed ID: 15566356
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunostimulatory oligodeoxynucleotides induce apoptosis of B cell chronic lymphocytic leukemia cells.
    Jahrsdörfer B; Wooldridge JE; Blackwell SE; Taylor CM; Griffith TS; Link BK; Weiner GJ
    J Leukoc Biol; 2005 Mar; 77(3):378-87. PubMed ID: 15582984
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rational design of new CpG oligonucleotides that combine B cell activation with high IFN-alpha induction in plasmacytoid dendritic cells.
    Hartmann G; Battiany J; Poeck H; Wagner M; Kerkmann M; Lubenow N; Rothenfusser S; Endres S
    Eur J Immunol; 2003 Jun; 33(6):1633-41. PubMed ID: 12778481
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structure-efficacy relationships of immunostimulatory activity of CpG-containing oligodeoxynucleotides on mouse spleen cells.
    Du HY; Xia SY; Song HF; Li N; Shang MM; Zou J; Wang QQ; Ou L; Sun X; Ji AG; Tang ZM
    Acta Pharmacol Sin; 2007 Oct; 28(10):1637-44. PubMed ID: 17883951
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bacterial DNA and immunostimulatory CpG oligonucleotides trigger maturation and activation of murine dendritic cells.
    Sparwasser T; Koch ES; Vabulas RM; Heeg K; Lipford GB; Ellwart JW; Wagner H
    Eur J Immunol; 1998 Jun; 28(6):2045-54. PubMed ID: 9645386
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of preactivated autologous T lymphocytes on CD80, CD86 and CD95 expression by chronic lymphocytic leukemia B cells.
    Romano C; De Fanis U; Sellitto A; Dalla Mora L; Chiurazzi F; Giunta R; Rotoli B; Lucivero G
    Leuk Lymphoma; 2003 Nov; 44(11):1963-71. PubMed ID: 14738151
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activation of marginal zone B cells from lupus mice with type A(D) CpG-oligodeoxynucleotides.
    Brummel R; Lenert P
    J Immunol; 2005 Feb; 174(4):2429-34. PubMed ID: 15699180
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activation with CpG-A and CpG-B oligonucleotides reveals two distinct regulatory pathways of type I IFN synthesis in human plasmacytoid dendritic cells.
    Kerkmann M; Rothenfusser S; Hornung V; Towarowski A; Wagner M; Sarris A; Giese T; Endres S; Hartmann G
    J Immunol; 2003 May; 170(9):4465-74. PubMed ID: 12707322
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CD40 triggering of chronic lymphocytic leukemia B cells results in efficient alloantigen presentation and cytotoxic T lymphocyte induction by up-regulation of CD80 and CD86 costimulatory molecules.
    Van den Hove LE; Van Gool SW; Vandenberghe P; Bakkus M; Thielemans K; Boogaerts MA; Ceuppens JL
    Leukemia; 1997 Apr; 11(4):572-80. PubMed ID: 9096698
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Autologous T lymphocytes may specifically recognize leukaemic B cells in patients with chronic lymphocytic leukaemia.
    Rezvany MR; Jeddi-Tehrani M; Rabbani H; Lewin N; Avila-Cariño J; Osterborg A; Wigzell H; Mellstedt H
    Br J Haematol; 2000 Nov; 111(2):608-17. PubMed ID: 11122109
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increase in tumor size following intratumoral injection of immunostimulatory CpG-containing oligonucleotides in a rat glioma model.
    Ginzkey C; Eicker SO; Marget M; Krause J; Brecht S; Westphal M; Hugo HH; Mehdorn HM; Steinmann J; Hamel W
    Cancer Immunol Immunother; 2010 Apr; 59(4):541-51. PubMed ID: 19798500
    [TBL] [Abstract][Full Text] [Related]  

  • 34. IFN-alpha stimulates proliferation and cytokine secretion of CD40-stimulated B cell chronic lymphocytic leukemia cells in vitro.
    Brass U; Tretter T; Schneller F; Schuler M; Huber C; Peschel C
    J Interferon Cytokine Res; 1999 Apr; 19(4):335-43. PubMed ID: 10334384
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oligodeoxynucleotides containing CpG motifs induce low levels of TNF-alpha in human B lymphocytes: possible adjuvants for Th1 responses.
    Bohle B; Orel L; Kraft D; Ebner C
    J Immunol; 2001 Mar; 166(6):3743-8. PubMed ID: 11238615
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CpG DNA increases primary malignant B cell expression of costimulatory molecules and target antigens.
    Jahrsdörfer B; Hartmann G; Racila E; Jackson W; Mühlenhoff L; Meinhardt G; Endres S; Link BK; Krieg AM; Weiner GJ
    J Leukoc Biol; 2001 Jan; 69(1):81-8. PubMed ID: 11200072
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CpG-A oligonucleotides induce a monocyte-derived dendritic cell-like phenotype that preferentially activates CD8 T cells.
    Krug A; Rothenfusser S; Selinger S; Bock C; Kerkmann M; Battiany J; Sarris A; Giese T; Speiser D; Endres S; Hartmann G
    J Immunol; 2003 Apr; 170(7):3468-77. PubMed ID: 12646607
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Selection of oligonucleotide aptamers with enhanced uptake and activation of human leukemia B cells.
    Wu CC; Castro JE; Motta M; Cottam HB; Kyburz D; Kipps TJ; Corr M; Carson DA
    Hum Gene Ther; 2003 Jun; 14(9):849-60. PubMed ID: 12828856
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Responsiveness of chronic lymphocytic leukemia B cells activated via surface Igs or CD40 to B-cell tropic factors.
    Fluckiger AC; Rossi JF; Bussel A; Bryon P; Banchereau J; Defrance T
    Blood; 1992 Dec; 80(12):3173-81. PubMed ID: 1281692
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunostimulatory properties of CpG-oligonucleotides are enhanced by the use of protamine nanoparticles.
    Kerkmann M; Lochmann D; Weyermann J; Marschner A; Poeck H; Wagner M; Battiany J; Zimmer A; Endres S; Hartmann G
    Oligonucleotides; 2006; 16(4):313-22. PubMed ID: 17155907
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.